Supply chain visibility and control key to building market share in pharma
Control and visibility are the two most vital aspects of a shipper’s pharma supply chain, ...
ID 150012582 © Vetre Antanaviciute-meskauskiene | Dreamstime.com
By Jack Riddick
You may not need to perform a thorough regression analysis of Kuehne + Nagel’s (K+N) income payout if you recall exactly how its distribution behaved in the past decade or so.
But you may need to go for it if you want to try and understand how the world’s largest forwarder ’thinks’ about the downturn, at a time when cost efficiency remains of paramount importance. And there’s a lot of that – on top of it being prepared cash-wise to take ...
Comment on this article